Literature DB >> 3871610

Unglycosylated rat alpha 1-proteinase inhibitor has a six-fold shorter plasma half-life than the mature glycoprotein.

W Weber, K Steube, V Gross, T A Tran-Thi, K Decker, W Gerok, P C Heinrich.   

Abstract

The plasma half-lives of glycosylated and unglycosylated alpha 1-proteinase inhibitor-radioactively labeled with [35S]methionine in rat hepatocyte primary cultures - were determined in the rat. Unglycosylated alpha 1-proteinase inhibitor was synthesized by hepatocytes in the presence of tunicamycin. Media from hepatocytes containing 35S-labeled glycosylated or unglycosylated alpha 1-proteinase inhibitor were injected into the tail veins of rats. At different times after injection alpha 1-proteinase inhibitor was isolated from plasma by affinity chromatography with anti-alpha 1-proteinase inhibitor Sepharose. Radioactivity measurements revealed a plasma half-life of 170 min for glycosylated alpha 1-proteinase inhibitor and of 30 min for the unglycosylated form of the inhibitor.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3871610     DOI: 10.1016/0006-291x(85)90652-7

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Site-specific enzymatic polysialylation of therapeutic proteins using bacterial enzymes.

Authors:  Theresa Lindhout; Umar Iqbal; Lisa M Willis; Anne N Reid; Jianjun Li; Xin Liu; Maria Moreno; Warren W Wakarchuk
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-18       Impact factor: 11.205

2.  Efficient and reproducible generation of high-expressing, stable human cell lines without need for antibiotic selection.

Authors:  Gudrun Schiedner; Sabine Hertel; Corinna Bialek; Helmut Kewes; Gero Waschütza; Christoph Volpers
Journal:  BMC Biotechnol       Date:  2008-02-12       Impact factor: 2.563

3.  Oxidation-resistant and thermostable forms of alpha-1 antitrypsin from Escherichia coli inclusion bodies.

Authors:  Wei Zhu; Lanfen Li; Mingjing Deng; Bo Wang; Mengfei Li; Guofang Ding; Zuisu Yang; Dan Medynski; Xiaotao Lin; Ying Ouyang; Jirui Lin; Luyuan Li; Xinli Lin
Journal:  FEBS Open Bio       Date:  2018-09-17       Impact factor: 2.693

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.